|
Euro Resistance Wk: Resistance Post Week 48 in ART-Experienced, Integrase Inhibitor-Naive Subjects With Dolutegravir (DTG) vs. Raltegravir (RAL) in SAILING (ING111762)
|
|
|
Reported by Jules Levin
13th European HIV & Hepatitis Workshop; June 3-5, 2015; Barcelona, Spain
MR Underwood,1 F DeAnda,1 D Dorey,2 K Hightower,1 R Wang,1 S Griffith,1 J Horton3
1GlaxoSmithKline, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Mississauga, ON, Canada; 3PAREXEL International, Research Triangle Park, NC, USA
![HCV1.gif](../images/061715/061715-7/HCV1.gif)
![HCV2.gif](../images/061715/061715-7/HCV2.gif)
![HCV3.gif](../images/061715/061715-7/HCV3.gif)
![HCV4.gif](../images/061715/061715-7/HCV4.gif)
|
|
|
|
|
|
|